REQUEST A DEMO
Total
USD $0.00
Search more companies

Patologia y Citologia S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Patologia y Citologia S.A.S. Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Patologia y Citologia S.A.S. is a company based in Colombia, with its head office in Floridablanca. It operates in the Diagnostic Imaging Centers industry. It was incorporated on May 09, 1978. It currently has a total number of 23 (2024) employees. There was a net sales revenue increase of 20.25% reported in Patologia y Citologia S.A.S.’s latest financial highlights for 2023. Its total assets grew by 6.47% over the same period. In, 2023, the company’s net profit margin increased by 7.06%.

Headquarters
Calle 158 # 20 - 95 Piso 0 Torre F
Floridablanca; Santander;

Contact Details: Purchase the Patologia y Citologia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Patologia y Citologia S.A.S. report to view the information.
Outstanding Shares:
Purchase the Patologia y Citologia S.A.S. report to view the information.
Incorporation Date:
May 09, 1978
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Patologia y Citologia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
20.25%
Total operating revenue
20.25%
Operating profit (EBIT)
77.28%
EBITDA
60.21%
Net Profit (Loss) for the Period
84.72%
Total assets
6.47%
Total equity
105.68%
Operating Profit Margin (ROS)
11.03%
Net Profit Margin
7.06%
Return on Equity (ROE)
-5.83%
Debt to Equity Ratio
-0.01%
Quick Ratio
0.68%
Cash Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?